Your browser doesn't support javascript.
loading
Association between the Prime Diet Quality Score and depressive symptoms in a Mediterranean population with metabolic syndrome. Cross-sectional and 2-year follow-up assessment from PREDIMED-PLUS study.
Cano-Ibáñez, Naomi; Serra-Majem, Lluis; Martín-Peláez, Sandra; Martínez-González, Miguel Ángel; Salas-Salvadó, Jordi; Corella Piquer, Maria Dolores; Lassale, Camille; Martínez Hernandez, José Alfredo; Alonso-Gómez, Ángel M; Wärnberg, Julia; Vioque Lopez, Jesús; Romaguera, Dora; López-Miranda, José; Estruch, Ramon; Gómez-Pérez, Ana María; Santos-Lozano, José Manuel; Fernández-Aranda, Fernando; Bueno-Cavanillas, Aurora; Tur, Josep A; Martín, Vicente; Pintó Sala, Xavier; Delgado-Rodríguez, Miguel; Matía Martín, Pilar; Vidal, Josep; Cárdenas, Jersy J; Daimiel Ruiz, Lidia; Ros, Emilio; Buil-Cosiales, Pilar; Becerra-Tomás, Nerea; Saiz, Carmen; Muñoz-Perez, Miguel-Ángel; Abete, Itziar; Tojal-Sierra, Lucas; Fernández-Barceló, Olga; Bernabé-Casanova, Andrea; Konieczna, Jadwiga; García-Ríos, Antonio; Casas, Rosa; Bernal-López, Maria Rosa; Lapetra, José; Toledo, Estefanía; Gómez-Martínez, Carlos; Coltell, Oscar; Malcampo-Manrúbia, Mireia; Zulet, María Angeles; Sorto-Sánchez, Carolina; Gea, Alfredo; Hernández-Fleta, José Luis; Castañer Niño, Olga; Sánchez-Villegas, Almudena.
Affiliation
  • Cano-Ibáñez N; Department of Preventive Medicine and Public Health, University of Granada, Granada, Spain.
  • Serra-Majem L; Centro de Investigación Biomédica en Red Epidemiología y Salud Pública (CIBERESP), Institute of Health Carlos III, Madrid, Spain.
  • Martín-Peláez S; Instituto de Investigación Biosanitaria de Granada (ibs.GRANADA), Granada, Spain.
  • Martínez-González MÁ; Consorcio CIBER, M.P. Fisiopatología de la Obesidad y la Nutrición (CIBERobn), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
  • Salas-Salvadó J; Research Institute of Biomedical and Health Sciences (IUIBS), University of Las Palmas de Gran Canaria, Las Palmas de Gran Canaria, Spain.
  • Corella Piquer MD; Department of Preventive Medicine and Public Health, University of Granada, Granada, Spain.
  • Lassale C; Instituto de Investigación Biosanitaria de Granada (ibs.GRANADA), Granada, Spain.
  • Martínez Hernandez JA; Consorcio CIBER, M.P. Fisiopatología de la Obesidad y la Nutrición (CIBERobn), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
  • Alonso-Gómez ÁM; University of Navarra, Department of Preventive Medicine and Public Health, IDISNA, Pamplona, Spain.
  • Wärnberg J; Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
  • Vioque Lopez J; Consorcio CIBER, M.P. Fisiopatología de la Obesidad y la Nutrición (CIBERobn), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
  • Romaguera D; Universitat Rovira i Virgili, Department de Bioquímica i Biotecnología, Unitat de Nutrició Humana, Reus, Spain.
  • López-Miranda J; Hospital Universitari San Joan de Reus, Human Nutrition Unit, Reus, Spain.
  • Estruch R; Institut d'Investigació Sanitària Pere Virgili (IISPV), Reus, Spain.
  • Gómez-Pérez AM; Consorcio CIBER, M.P. Fisiopatología de la Obesidad y la Nutrición (CIBERobn), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
  • Santos-Lozano JM; Department of Preventive Medicine, University of Valencia, Valencia, Spain.
  • Fernández-Aranda F; Consorcio CIBER, M.P. Fisiopatología de la Obesidad y la Nutrición (CIBERobn), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
  • Bueno-Cavanillas A; Cardiovascular Risk and Nutrition Research Group, Hospital del Mar Medical Research Institute (IMIM), Barcelona, Spain.
  • Tur JA; Department of Nutrition, Food Sciences and Physiology, Center for Nutrition Research, University of Navarra, IdisNA, Pamplona, Spain.
  • Martín V; Nutritional Control of the Epigenome, Precision Nutrition and Obesity Program IMDEA Food, CEI UAM + CSIC, Madrid, Spain.
  • Pintó Sala X; Consorcio CIBER, M.P. Fisiopatología de la Obesidad y la Nutrición (CIBERobn), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
  • Delgado-Rodríguez M; Bioaraba Health Research Institute, Cardiovascular, Respiratory and Metabolic Area, Osakidetza Basque Health Service, Araba University Hospital, University of the Basque Country UPV/EHU, Vitoria-Gasteiz, Spain.
  • Matía Martín P; Consorcio CIBER, M.P. Fisiopatología de la Obesidad y la Nutrición (CIBERobn), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
  • Vidal J; Department of Nursing, School of Health Sciences, University of Malaga-Instituto de Investigación Biomédica de Málaga (IBIMA), Málaga, Spain.
  • Cárdenas JJ; Centro de Investigación Biomédica en Red Epidemiología y Salud Pública (CIBERESP), Institute of Health Carlos III, Madrid, Spain.
  • Daimiel Ruiz L; Instituto de Investigación Sanitario y Biomédica de Alicante, (ISABIAL-UMH), Alicante, Spain.
  • Ros E; Consorcio CIBER, M.P. Fisiopatología de la Obesidad y la Nutrición (CIBERobn), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
  • Buil-Cosiales P; Health Research Institute of the Balearic Islands (IdISBa), Palma de Mallorca, Spain.
  • Becerra-Tomás N; Consorcio CIBER, M.P. Fisiopatología de la Obesidad y la Nutrición (CIBERobn), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
  • Saiz C; Lipids and Atherosclerosis Unit, Department of Internal Medicine, Maimonides Biomedical Research Institute of Córdoba (IMIBIC), Reina Sofía University Hospital, University of Córdoba, Córdoba, Spain.
  • Muñoz-Perez MÁ; Consorcio CIBER, M.P. Fisiopatología de la Obesidad y la Nutrición (CIBERobn), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
  • Abete I; Department of Internal Medicine, Institut dÌnvestigacions Biomèdiques August Pi Sunyer (IDIBAPS), Hospital Clinic, University of Barcelona, Barcelona, Spain.
  • Tojal-Sierra L; Consorcio CIBER, M.P. Fisiopatología de la Obesidad y la Nutrición (CIBERobn), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
  • Fernández-Barceló O; Virgen de la Victoria Hospital, Department of Endocrinology, Instituto de Investigación Biomédica de Málga (IBIMA), University of Málaga, Málaga, Spain.
  • Bernabé-Casanova A; Consorcio CIBER, M.P. Fisiopatología de la Obesidad y la Nutrición (CIBERobn), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
  • Konieczna J; Department of Family Medicine, Research Unit, Distrito Sanitario Atención Primaria Sevilla, Sevilla, Spain.
  • García-Ríos A; Consorcio CIBER, M.P. Fisiopatología de la Obesidad y la Nutrición (CIBERobn), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
  • Casas R; Department of Psychiatry, University Hospital of Bellvitge-IDIBELL and School of Medicine and Health Sciences, University of Barcelona, Barcelona, Spain.
  • Bernal-López MR; Department of Preventive Medicine and Public Health, University of Granada, Granada, Spain.
  • Lapetra J; Centro de Investigación Biomédica en Red Epidemiología y Salud Pública (CIBERESP), Institute of Health Carlos III, Madrid, Spain.
  • Toledo E; Instituto de Investigación Biosanitaria de Granada (ibs.GRANADA), Granada, Spain.
  • Gómez-Martínez C; Consorcio CIBER, M.P. Fisiopatología de la Obesidad y la Nutrición (CIBERobn), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
  • Coltell O; Research Group on Community Nutrition & Oxidative Stress, University of Balearic Islands, Palma de Mallorca, Spain.
  • Malcampo-Manrúbia M; Centro de Investigación Biomédica en Red Epidemiología y Salud Pública (CIBERESP), Institute of Health Carlos III, Madrid, Spain.
  • Zulet MA; Institute of Biomedicine (IBIOMED), University of León, León, Spain.
  • Sorto-Sánchez C; Consorcio CIBER, M.P. Fisiopatología de la Obesidad y la Nutrición (CIBERobn), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
  • Gea A; Lipids and Vascular Risk Unit, Internal Medicine, Hospital Universitario de Bellvitge, Hospitalet de Llobregat, Barcelona, Spain.
  • Hernández-Fleta JL; Centro de Investigación Biomédica en Red Epidemiología y Salud Pública (CIBERESP), Institute of Health Carlos III, Madrid, Spain.
  • Castañer Niño O; Center for Advanced Studies in Olive Grove and Olive Oils, University of Jaén, Jaén, Spain.
  • Sánchez-Villegas A; Department of Endocrinology and Nutrition, Instituto de Investigación Sanitaria Hospital Clínico San Carlos (IdISSC), Madrid, Spain.
Br J Nutr ; 128(6): 1170-1179, 2022 09 28.
Article in En | MEDLINE | ID: mdl-34713791
ABSTRACT
The burden of depression is increasing worldwide, specifically in older adults. Unhealthy dietary patterns may partly explain this phenomenon. In the Spanish PREDIMED-Plus study, we explored (1) the cross-sectional association between the adherence to the Prime Diet Quality Score (PDQS), an a priori-defined high-quality food pattern, and the prevalence of depressive symptoms at baseline (cross-sectional analysis) and (2) the prospective association of baseline PDQS with changes in depressive symptomatology after 2 years of follow-up. After exclusions, we assessed 6612 participants in the cross-sectional analysis and 5523 participants in the prospective analysis. An energy-adjusted high-quality dietary score (PDQS) was assessed using a validated FFQ. The cross-sectional association between PDQS and the prevalence of depression or presence of depressive symptoms and the prospective changes in depressive symptoms were evaluated through multivariable regression models (logistic and linear models and mixed linear-effects models). PDQS was inversely associated with depressive status in the cross-sectional analysis. Participants in the highest quintile of PDQS (Q5) showed a significantly reduced odds of depression prevalence as compared to participants in the lowest quartile of PDQS (Q1) (OR (95 %) CI = 0·82 (0·68, 0·98))). The baseline prevalence of depression decreased across PDQS quintiles (Pfor trend = 0·015). A statistically significant association between PDQS and changes in depressive symptoms after 2-years follow-up was found (ß (95 %) CI = -0·67 z-score (-1·17, -0·18). A higher PDQS was cross-sectionally related to a lower depressive status. Nevertheless, the null finding in our prospective analysis raises the possibility of reverse causality. Further prospective investigation is required to ascertain the association between PDQS and changes in depressive symptoms along time.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Metabolic Syndrome / Diet, Mediterranean Type of study: Diagnostic_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Humans Language: En Journal: Br J Nutr Year: 2022 Type: Article Affiliation country: Spain

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Metabolic Syndrome / Diet, Mediterranean Type of study: Diagnostic_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Humans Language: En Journal: Br J Nutr Year: 2022 Type: Article Affiliation country: Spain